Company intelligence / Profile preview

Alnaba

Ownership: Private
Development stage: Other

Overview

Alna Biotech operates as an ISO and GMP-certified pharmaceutical manufacturer with a portfolio exceeding 3000 products in multiple dosage forms. It supplies to domestic and international markets with a focus on quality manufacturing for diverse therapeutic needs. No clinical trial results are published; the business model centers on commercial supply rather than novel drug development.

Modalities: Small moleculeProteinHerbal/Ayurvedic productsNutraceuticals
Industry: Contract Manufacturing Organization

Partnerships

Tie-ups with companies in Vietnam and Thailand for cosmetic/dermatology products

Beyond the preview

Go deeper on Alnaba.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alnaba.

Explore the full profile